{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-058791","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.681297+00:00","generated_at":"2026-05-16T12:17:18.994008+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Ginkgo Bioworks COO Reshma Shetty transitions role; Jennifer Wipf assumes ops duties","bullets":["Dr. Reshma Shetty steps down as COO effective Jan 1, 2026; remains President and Board member.","She will focus on expanding autonomous lab for cell engineering service offerings.","CEO Dr. Jason Kelly assumes principal operating officer oversight duties.","Jennifer Wipf (ex-CCO/GM) takes on day-to-day operations, reporting to Kelly.","Wipf brings vaccine and plant management experience from over a decade at Merck."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-058791","json":"https://secwatch.observer/filing/0001628280-25-058791.json","markdown":"https://secwatch.observer/filing/0001628280-25-058791.md","text":"https://secwatch.observer/filing/0001628280-25-058791.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025058791/0001628280-25-058791-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025058791/dna-20251218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:17:18.994008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}